Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GCBP Sponsors 2024 Spring Symposium for KASBP and Present Research Findings 2024-06-04 13:00
Fapon Biopharma Announces a Safer Immunotherapy for Cancers 2024-06-04 09:42
Datasea Agreement already provided $2.8 million Information Service for its Highly Specialized 5G-AI Communications Platform 2024-06-03 22:00
Minghui Pharmaceutical Presents Phase 1/2 Clinical Data of MHB088C (B7-H3 ADC) as Monotherapy for the Treatment of Patients with Recurrent or Metastatic Solid Tumors at the 2024 ASCO Annual Meeting 2024-06-03 21:30
Visionary Pioneering Innovation Across Four Key Frontiers 2024-06-03 20:30
Formosa Laboratories Completes the Acquisition of Synchem to Expand North American CDMO Footprint 2024-06-03 13:01
MGI Tech's DNBSEQ-E25 and G99 Platforms Set Record for Sequencing Applications on Mount Everest 2024-06-03 11:35
Leads Biolabs' Innovative Cancer Treatment LBL-024, an Anti-PDL1/4-1BB Bispecific Antibody Achieved Outstanding Phase II Results, Has Been Presented in Clinical Science Symposium at 2024 ASCO Annual Meeting. 2024-06-03 10:57
GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024 ASCO Annual Meeting 2024-06-02 07:13
Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting 2024-06-02 03:00
Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Platform: ImmuAlpaca® Mouse 2024-06-01 20:00
TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024 Annual Meeting 2024-06-01 20:00
Neurophet to participate BIO USA… exploring global partnership and business 2024-05-31 21:00
Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC 2024-05-31 02:21
OBiO Technology Officially Launched the Center for Clinical Evaluation and Translation of Advanced Therapies for Pediatric Rare and Genetic Diseases 2024-05-30 21:00
Kexing Biopharm Obtained Clinical Trial Approval for its Self-developed Class I Innovative Drug--Long-acting Growth Hormone 2024-05-30 17:09
Full-Life Technologies Announces Clearance from FDA of IND Application for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer 2024-05-30 08:00
GV Innovation High-Value Niche Market Transformation Project 2024-05-29 20:30
HuidaGene and Synthego Announce Licensing Agreement on Next-Generation Gene Editing Enzyme, hfCas12Max 2024-05-29 19:30
GC Cell participates 2024 BIO International Convention, Unveiling its future Blueprint 2.0, as the First Korean Business Forum Sponsor 2024-05-28 23:00
1 15 16 17 18 19 222